Combined effect of parathyroid hormone and strontium ranelate on bone healing in ovariectomized rats
Erişim
info:eu-repo/semantics/closedAccessTarih
2018Yazar
Goker, FundaErsanli, Selim
Arisan, Volkan
Cevher, Erdal
Guzel, Emine Elif
Issever, Halim
Omer, Beyhan
Altun, Gulay Durmus
Morina, Deniz
Yilmaz, Tugba Ekiz
Dervisoglu, Elmire
Del Fabbro, Massimo
Üst veri
Tüm öğe kaydını gösterKünye
Göker, F., Ersanlı, S., Arısan, V., Cevher, E., Güzel, E. E., İşsever, H., ... & Dervişoğlu, E. (2018). Combined effect of parathyroid hormone and strontium ranelate on bone healing in ovariectomized rats. Oral diseases, 24(7), 1255-1269.Özet
ObjectiveParathyroid hormone (PTH) enhances bone healing. Strontium ranelate (SR) is an antiresorptive agent that increases bone formation. Reports about combined effects of PTH and SR on local bone regeneration in osteoporotic subjects are limited. We aimed at investigating the efficacy of PTH and SR for promoting new bone formation in critical-sized defects of ovariectomized rats.
Materials and MethodsParathyroid hormone- and/or SR-containing poloxamer implant tablets with/without chitosan microparticles were delivered locally to calvarial defects of 90 Wistar rats. Biopsies were analyzed histologically and histomorphometrically at 4 and 8weeks of healing.
ResultsHistomorphometry revealed that PTH alone promoted new bone formation at 4weeks but the efficiency declined in 8weeks. There was no positive effect of SR alone on bone formation at 4 or 8weeks. Calvarial defects treated with PTH+SR combinations showed statistically significant greater new bone formation than either treatment alone at both time intervals. Tissue responses were modest and supported the good biocompatibility of the biomaterials used.
ConclusionParathyroid hormone and SR combinations can be effective for calvarial bone regeneration of ovariectomized rats. PTH plus SR may have potential use as bone graft material in orthopedic and dental surgery to enhance bone healing and osseointegration.